Testosterone therapy in relation to prostate cancer in a US commercial insurance claims database

BACKGROUND: We conducted a study assess whether testosterone therapy (TT) alters prostate cancer risk using a large US commercial insurance research database. METHODS: From the HealthCore Integrated Research Database (HIRD(SM)), we selected men aged 30 years or greater who were new users of TT durin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Epidemiol Biomarkers Prev
Hlavní autoři: Cook, Michael B., Beachler, Daniel C., Parlett, Lauren E., Cochetti, Philip T., Finkle, William D., Lanes, Stephan, Hoover, Robert N.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954307/
https://ncbi.nlm.nih.gov/pubmed/31641011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0619
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky